Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc. filings document a global professional services firm with businesses in risk, reinsurance and capital, people and investments, and management consulting. The record includes 8-K reports for quarterly and annual operating results, officer appointments and compensation actions, director changes, bylaw amendments, and other material events.
Proxy materials describe annual meeting matters, board governance, executive compensation and stockholder voting. Capital-market filings cover common stock registered on the New York Stock Exchange and NYSE Texas, shelf registration use, underwriting agreements, senior notes, indenture supplements and related exhibits for the company's advisory and consulting businesses.
Marsh & McLennan Companies, Inc. (MMC) reported an insider equity transaction by one of its directors. On 11/14/2025, the director acquired 96.91 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, recorded as a transaction code J.
The filing shows these units were credited as dividend equivalents to the director’s account, meaning additional units were granted in lieu of cash dividends. Each restricted stock unit converts into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, the director beneficially owned 19,849.64 derivative securities (restricted stock units) held directly, with a reported derivative security price of $183.435.
Marsh & McLennan Companies director reports additional stock units. A director of MARSH & MCLENNAN COMPANIES, INC. (MMC) reported an acquisition of derivative securities on 11/14/2025. The filing shows the director received 37.37 restricted stock units through dividend equivalents credited under the Marsh & McLennan Companies Directors Stock Compensation Plan. These units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, the director beneficially owned 7,653.6 restricted stock units, held in direct ownership.
Marsh & McLennan Companies (MMC) reported a Form 4 filing showing a director’s routine equity compensation activity. On 11/14/2025, the director acquired 50.26 restricted stock units credited as dividend equivalents under the Marsh & McLennan Companies Directors Stock Compensation Plan. Each unit converts into one share of Marsh & McLennan common stock.
On 11/15/2025, the same director acquired an additional 197.78 restricted stock units in connection with director fees under the same plan. Following these transactions, the director beneficially owns 10,491.67 restricted stock units, held directly.
Marsh & McLennan Companies (MMC) reported a director equity transaction on Form 4. On 11/14/2025, the director had 34.22 restricted stock units under the Directors Stock Compensation Plan credited as dividend equivalents, each convertible into one share of common stock. On 11/15/2025, the director acquired an additional 148.34 restricted stock units in connection with director fees under the same plan. The reported prices were $183.435 and $183.28 per unit, and following these transactions the director directly beneficially owned 7,157.45 restricted stock units.
Marsh & McLennan Companies (MMC) director reports small equity award. A company director filed a Form 4 showing the acquisition of 4.58 restricted stock units on 11/14/2025 under the Marsh & McLennan Companies Directors Stock Compensation Plan. These units were credited as dividend equivalents, meaning the director received additional units in lieu of cash dividends. Each restricted stock unit converts into one share of Marsh & McLennan common stock. The filing reports a price of $183.435 per unit and shows the director now beneficially owns 938.25 derivative securities in this form, held directly. This reflects routine director equity compensation rather than a market purchase or sale.
Marsh & McLennan Companies, Inc. (MMC) reported a Form 4 insider transaction for a director. On 11/15/2025, the director acquired 231 shares of common stock at $183.28 per share, received as compensation under the Marsh & McLennan Companies Directors Stock Compensation Plan rather than through an open-market purchase. Following this grant, the director beneficially owns 3,900.75 shares directly and 47,553 shares indirectly through a trust, showing both personal and trust-based holdings in the company.
Marsh & McLennan Companies (MMC) reported solid top-line growth in Q3 2025. Revenue rose to $6,351 million from $5,697 million, while net income attributable to the company held steady at $747 million. Diluted EPS was $1.51, unchanged year over year. For the first nine months, revenue reached $20,386 million versus $18,391 million, and net income rose to $3,339 million from $3,272 million.
Risk & Insurance Services delivered $3,907 million in Q3 revenue (up from $3,453 million), led by Marsh at $3,400 million and Guy Carpenter at $398 million. Consulting generated $2,465 million (up from $2,262 million), with Mercer at $1,579 million and Oliver Wyman Group at $886 million.
Operating cash flow strengthened to $3,131 million year-to-date (from $2,346 million), supporting $1,255 million in dividends and $1,002 million in share repurchases. The company completed multiple acquisitions across Marsh, MMA, Mercer, and Oliver Wyman; year-to-date acquisition-related expenses were $218 million, including $166 million tied to McGriff integration and retention. Shares outstanding were 489,909,683 as of October 13, 2025.
Marsh & McLennan Companies (MMC) furnished a press release announcing financial results for the third quarter ended September 30, 2025. The company also scheduled a conference call to discuss the results at 8:00 a.m. Eastern time on October 16, 2025.
The press release was provided as Exhibit 99.1 and is deemed furnished, not filed, under Section 18 of the Exchange Act.
Marsh & McLennan Companies insider transaction by John Q. Doyle. The filing reports that on 09/02/2025 Mr. Doyle exercised 21,079 stock options with an exercise price of $63.09 and immediately sold 21,079 shares at $205.65 per share. The transactions were executed pursuant to a previously adopted Rule 10b5-1 trading plan. After these transactions Mr. Doyle beneficially owned 87,681.0205 shares of MMC directly. The options exercised were originally granted on May 1, 2016 and vested in four equal annual installments beginning May 1, 2017, with full vesting by 2020.
Marsh & McLennan Companies, Inc. (MMC) filed a Form 144 reporting a proposed sale of 21,079 common shares through Fidelity Brokerage Services (Smithfield, RI) with an aggregate market value of $4,334,896.35. The filing lists the approximate date of sale as 09/02/2025 and reports 491,624,043 shares outstanding, indicating the sale will be executed on the NYSE. The securities are reported as acquired in connection with options granted 05/01/2016, with the acquisition date shown as 09/02/2025 and payment noted as cash. The filer also disclosed a prior sale on 06/02/2025 by John Q. Doyle of 21,080 shares for gross proceeds of $4,891,614.00. The notice includes the standard representation that the selling person does not possess undisclosed material adverse information.